Needham & Company LLC Issues Pessimistic Forecast for Vital Farms (NASDAQ:VITL) Stock Price

Vital Farms (NASDAQ:VITL) had its price objective cut by stock analysts at Needham & Company LLC from $14.00 to $13.00 in a report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC‘s target price points to a potential upside of 29.74% from the stock’s current price.

Several other research analysts also recently commented on the company. Benchmark raised Vital Farms from a “hold” rating to a “buy” rating in a research note on Thursday, August 6th. TD Cowen lowered their target price on shares of Vital Farms from $11.00 to $8.00 and set a “hold” rating on the stock in a research note on Tuesday, October 13th. Weiss Ratings lowered shares of Vital Farms from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, September 29th. Craig Hallum raised shares of Vital Farms from a “hold” rating to a “buy” rating and set a $12.00 target price for the company in a report on Tuesday. Finally, BMO Capital Markets restated an “outperform” rating on shares of Vital Farms in a research report on Wednesday. Six equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Vital Farms has an average rating of “Hold” and a consensus target price of $16.45.

Vital Farms Price Performance

NASDAQ:VITL opened at $10.02 on Wednesday. The stock has a 50 day moving average of $9.73 and a two-hundred day moving average of $13.96. Vital Farms has a 12 month low of $7.95 and a 12 month high of $38.64. The firm has a market cap of $430.16 million, a P/E ratio of -250.50 and a beta of 1.16. The company has a current ratio of 1.10, a quick ratio of 0.60 and a debt-to-equity ratio of 0.11.

Vital Farms (NASDAQ:VITL) last released its earnings results on Tuesday, November 3rd. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.04). The firm had revenue of $182.16 million during the quarter, compared to analysts’ expectations of $181.78 million. Vital Farms had a net margin of 0.02% and a return on equity of 3.46%. The business’s revenue was down 8.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.36 EPS. On average, analysts expect that Vital Farms will post -0.53 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Vital Farms

A number of institutional investors have recently bought and sold shares of VITL. Allspring Global Investments Holdings LLC lifted its position in Vital Farms by 11.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 14,102 shares of the company’s stock valued at $199,000 after buying an additional 1,438 shares during the last quarter. Keebeck Wealth Management increased its position in shares of Vital Farms by 16.5% during the first quarter. Keebeck Wealth Management now owns 10,707 shares of the company’s stock valued at $151,000 after acquiring an additional 1,513 shares during the last quarter. Raiffeisen Bank International AG increased its position in shares of Vital Farms by 8.0% during the second quarter. Raiffeisen Bank International AG now owns 27,000 shares of the company’s stock valued at $305,000 after acquiring an additional 2,000 shares during the last quarter. Assetmark Inc. increased its position in shares of Vital Farms by 53.7% during the first quarter. Assetmark Inc. now owns 5,732 shares of the company’s stock valued at $81,000 after acquiring an additional 2,002 shares during the last quarter. Finally, Signaturefd LLC raised its stake in shares of Vital Farms by 53.6% in the 3rd quarter. Signaturefd LLC now owns 5,829 shares of the company’s stock valued at $54,000 after acquiring an additional 2,035 shares during the period. 98.59% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Craig Hallum upgraded VITL from “hold” to “buy” and set a $12 price target, citing potential upside from the share price reported at the time. Craig Hallum rating
• Negative Sentiment: Q3 results showed a loss of $0.15 per share, worse than the roughly $0.11–$0.13 loss expected, versus earnings of $0.36 a year earlier. Revenue was about $182.2 million—near analyst estimates—but down 8.4% year over year. Q3 results
• Negative Sentiment: Vital Farms expects approximately $730 million in 2026 net sales but an adjusted EBITDA loss of about $15 million, and withdrew its 2030 targets. The weaker profitability outlook and reduced long-term visibility weigh on the investment case. 2026 outlook
• Negative Sentiment: A report also flagged litigation and accounting/financial-operations risks amid volatile egg markets, adding uncertainty for investors. Risk report

Vital Farms Company Profile

Vital Farms, Inc is a food company that produces and markets pasture-raised eggs and other ethically sourced food products. Its offerings include pasture-raised eggs, butter, hard-boiled eggs and ghee, sold under the Vital Farms brand.

Founded in 2007, the company works with a network of family farms and focuses on animal welfare, outdoor access and supply-chain transparency. Vital Farms products are distributed primarily through grocery retailers and other food channels across the United States.

Vital Farms is headquartered in Austin, Texas.